Subscribe to Imaging
View Sample

FREE Email Newsletter

MKS Instruments Announces Third Quarter 2010 Earnings Conference Call

October 13, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

ANDOVER, Mass., Oct. 13 /- MKS Instruments, Inc. (Nasdaq: MKSI ), a global provider of technologies that enable advanced processes and improve productivity, today announced that it will release third quarter 2010 financial results after market close on Wednesday, October 20, 2010.  A...

Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therap...

October 13, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

DALLAS, Oct. 13 /- Highland Capital Management, L.P. ("Highland"), a Dallas-based, SEC-registered investment adviser with approximately $22 billion of assets under management, announced today that American HomePatient, Inc. ("American HomePatient" or "the Company") --  which...

Boston Scientific Announces Global Launch of Journey™ Guidewire

October 13, 2010 4:31 am | by Boston Scientific | News | Comments

Major advance in guidewire technology for challenging peripheral interventions


The Partnership at Comments on FDA Approval of Alkermes Opioid Dependence Medication

October 13, 2010 12:31 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 13 /PRNewswire-USNewswire/ --   The U.S. Food and Drug Administration's approval of Alkermes' opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive news for families of young adults and...

Cellectis bioresearch Announces Establishment of Subsidiary in the US

October 13, 2010 12:31 am | by Bio-Medicine.Org | News | Comments

PARIS, Oct. 13 /- Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis (Alternext: ALCLS), today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts,...

Study Demonstrates Pine Bark Naturally Improves Tinnitus

October 13, 2010 12:31 am | by Bio-Medicine.Org | News | Comments

HOBOKEN, N.J., Oct. 13 /- More than 50 million Americans will experience some degree of tinnitus in their lifetime, according to the American Tinnitus Association.  Tinnitus is a hearing condition that causes the constant misperception of sound, including hissing, ringing and rushing...

Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call

October 12, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Oct. 12 /- Express Scripts (Nasdaq: ESRX ), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings and 2011 earnings guidance on Wednesday, October 27, 2010 after the market closes and will...

Misonix Announces Change in Distribution of SonaStar® Surgical Aspiration System in the U.S.

October 12, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Oct. 12 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has announced a definitive agreement to end its non-exclusive distribution arrangement in the United...


Results of Innovative Clinical Study Show New Combination for Weight Loss Success

October 12, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 12 /- As the weight loss and fitness industry thought leaders gathered this week to discuss the nation's obesity epidemic, a new research study presented at the conference identified a new formula for weight loss success. BodyMedia, Inc., the pioneer in developing wearable...

Burrill & Company and Infinity Group Form Joint Venture Focusing on Life Science Opportunities in China

October 12, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO and HONG KONG, Oct. 12 /- Burrill & Company, a leading life sciences venture capital/private equity firm and Infinity Group, an RMB fund pioneer and the leading cross border China dollar and RMB private equity fund announced today that they have established a strategic...

General Dynamics Awarded Contract to Outfit and Transition U.S. Army Medical Facilities

October 12, 2010 9:31 am | by Bio-Medicine.Org | News | Comments

FAIRFAX, Va., Oct. 12 /- General Dynamics Information Technology, a business unit of General Dynamics (NYSE: GD ), has been awarded a contract to support the U.S. Army Medical Department's healthcare construction projects, including modernization of current Army medical facilities and...

WPI Holdings Acquires Wilmington Medical Supply Inc.

October 12, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

OCEANSIDE, N.Y., Oct. 12 /- WPI Holdings d/b/a Woodbury Health Products ("Woodbury"), a portfolio company of HealthEdge Investment Partners, LLC ("HealthEdge"), announced today that it has completed the acquisition of Wilmington Medical Supply Inc. ("WMS"). Based in Wilmington, North...

Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimer's Disease and Cognitive Decline

October 12, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Oct. 12 /- Adeona Pharmaceuticals, Inc., (Amex: AEN ) announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer's disease and cognitive decline. The author of all these publications is Adeona's scientific founder and...


Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012

October 12, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 12 /- announces that a new market research report is available in its catalogue: Imaging Diagnostics Market In Poland 2010 - Development Forecasts For 2010-2012...

Unique Cancer Survivors' Summit Unites Patients From Across the Nation to Celebrate Life

October 11, 2010 11:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 11 /- More than 120 cancer survivors and caregivers, cancer-treating physicians, and patient advocates gathered in San Diego to share their Proleukin® (aldesleukin for injection) treatment experiences.  The theme of the meeting, Celebrating Our (Un)Common Journey...

Kaiser Permanente Leads the Nation in 12 Quality Measures

October 11, 2010 11:32 am | by Bio-Medicine.Org | News | Comments

OAKLAND, Calif., Oct. 11 /- Kaiser Permanente leads the nation among all reporting commercial health plans with top marks in 12 quality measures. These conclusions were based on information in the 2010 National Committee for Quality Assurance's Quality Compass® data. Kaiser...

Pioneer® Surgical Technology, Inc. Announces Plans to Establish Manufacturing and Distribution Facility in Ireland

October 11, 2010 11:32 am | by Bio-Medicine.Org | News | Comments

MARQUETTE, Mich., Oct. 11 /- Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced today the company's plan to establish a manufacturing and distribution facility in Ireland.  Pioneer has initiated discussions with the IDA (Ireland Development...

Apollo Endosurgery Completes First Clinical Case with Newly-Launched FlexShears™ Endoscopic Scissors

October 11, 2010 11:31 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Oct. 11 /- Apollo Endosurgery, Inc. announced completion of the first clinical case involving its FlexShears™ Endoscopic Scissors.  The new device was used to cut and remove an obstructing eroded suture from the patient's GI tract in a procedure that embodies the...

Express Scripts Accurately Predicts Which Patients Are Likely to Ignore Doctors' Orders

October 11, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Oct. 11 /- Through a set of proprietary computer models, Express Scripts, Inc. (Nasdaq: ESRX ), is now able to accurately predict up to a year in advance which patients are most at risk of falling off their physician-prescribed drug therapy — and to intervene in...

Arable Corporation Announces New Technology for Clinical Trial Industry

October 11, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Oct. 11 /- Arable Corporation ( ) has announced the launch of Arable Perform to bring unique CTMS technologies to the clinical trial industry.  Whereas traditional CTMS systems have been costly and require months to implement, Perform brings CTMS...

TriReme Medical Announces $17 Million Series D Financing

October 11, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., Oct. 11 /- TriReme Medical, a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the closing of a $17M Round D financing.  The financing was led by Bio*One Capital, a subsidiary of Singapore based...

Varian Medical Systems and Stanford University Win $3.6 Million Five-Year NIH/NCI Research Grant to Develop Advanced Imaging Technology

October 11, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Oct. 11 /- Scientists from Stanford University and from the Ginzton Technology Center at Varian Medical Systems have jointly received a $3.6 million five-year research grant from the U.S. National Institutes of Health (NIH) to develop advanced imaging technology...

Chongqing Cancer Hospital Becomes First Hospital in Southwest China to Offer Cancer Patients Fast, Precise Treatment Using RapidArc® Radiotherapy from Varian Medical Systems

October 11, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

BEIJING, and PALO ALTO, Calif., Oct. 11 /- Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while...

MuGard Provides Significant Improvement or Stabilization of Oral Mucositis in Over 75% of Patients in European Clinical Experience

October 11, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

DALLAS and NEW YORK, Oct. 11 /- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP ), a biopharmaceutical company specializing in products for cancer and supportive care, announced the highlights from a poster presentation on European clinical experience of MuGard at this year's...

DATATRAK Awarded Three Phase III Studies

October 11, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Oct. 11 /- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of an Enterprise Agreement for three new Phase III oncology studies with an existing...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.